-
Uncategorized3 weeks ago
The next big pharma company will come from China
The next big pharma company will come from China
-
Uncategorized3 weeks ago
Lilly and Engage Bio tie the knot with $202M acquisition
Eli Lilly joins hands with Engage Bio, acquiring the DNA delivery platform developer in hopes of bolstering its genetic medicines portfolio.
-
Uncategorized3 weeks agoOpinion: I saw Ebola as both doctor and patient. I wish people cared more about the Africans I worked alongside
Amid another Ebola outbreak, hundreds of Africans are sick, displaced, fearful, or dead. Health care workers across Central Africa are once again caring for patients in...
-
Uncategorized3 weeks agoSTAT+: Kennedy fires two leaders on preventive services task force
WASHINGTON — Health secretary Robert F. Kennedy Jr. has fired two leaders of a panel that advises the federal government on which preventive services should be...
-
Uncategorized3 weeks ago
Standardizing Cell Therapy Production With Technology Facelift
Standardizing Cell Therapy Production With Technology Facelift
-
Uncategorized3 weeks agoUniversity of Dundee leads effort to tackle ‘cruel’ disease
The University of Dundee has revealed plans to develop therapies to tackle a deadly tropical disease. The £10 million ($13.4 million) project will accelerate research on new therapies...
-
Uncategorized3 weeks ago
After raising $800M, Parabilis seeks an IPO to pursue ‘undruggable’ targets
Parabilis is teeing up the latest high-profile stock issuance in a year when biotech IPOs are averaging more than $286 million in total proceeds.
-
Uncategorized3 weeks ago
Bristol Myers deepens AI investment with Anthropic deal
The collaboration marks an “evolution” in the pharmaceutical giant’s use of AI and adds to a series of broad deals its peers have used to adopt...
-
Uncategorized3 weeks ago
FDA sends warning letter after Chinese supplier breaks GLP-1 import restrictions
While the manufacturer is on the list of authorized GLP-1 importers, FDA inspectors found the company relabeled APIs from another site in a potential attempt to...
-
Uncategorized3 weeks ago
Pfizer’s next-gen pneumonia shot beats Prevnar 20; Relay targets $175M
💉 Pfizer’s experimental 25-valent pneumococcal shot beats Prevnar 20: The vaccine candidate, codenamed PF-07872412, produced higher geometric mean titers for serotype 3 than Pfizer’s approved 20-valent...
Amgen shores up Tavneos’ FDA defense with Duke data analysis
